Navigation Links
Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in China in May
Date:5/5/2008

CINCINNATI, May 5 /PRNewswire/ -- Medpace, a leading global full-service contract research organization, announced that Jim Wei, MD, PhD, Medpace Director of Clinical Pharmacology, will address three international conferences in China in May. He will speak at the Impact China IV Conference in Beijing, at the International Workshop on Mass Spectrometry and New Drug Development in Hangzhou, and at the International Society for the Study of Xenobiotics in Shanghai.

At the Impact China IV Conference in Beijing, China on 4-6 May, Dr. Wei will speak on "The Role of Foreign Data and FDA Requirements." In his presentation he will discuss how both pre-clinical and clinical data from foreign countries has increased in Investigational New Drug Application (IND), New Drug Application (NDA), and Biologic License Application (BLA) submissions in the US.

Dr. Wei will talk about "Current FDA Policy and Opportunities for the Chinese Pharmaceutical Industry" at the International Workshop on Mass Spectrometry and New Drug Development in Hangzhou, China on 8-10 May. In his presentation Dr. Wei will discuss regulatory policies that would help Chinese generic suppliers and the opportunities for botanical drug products in the US market.

At the Second Asian Pacific Regional Meeting of the International Society for The Study of Xenobiotics, held in Shanghai, China on 11-13 May, Dr. Wei will speak on the "Current US FDA Recommendations on Drug Interaction Studies and Challenges to the Pharmaceutical Industry." In this presentation he will reveal the challenges to the pharmaceutical industry -- the requirement of the knowledge level of drug metabolism and drug interactions, optimal design of in vitro and in vivo studies, and integrated analyses to assess the risk/benefit ratio of new drugs for potential harmful drug interactions.

Dr. Wei joined Medpace in November 2007 with extensive experience in the clinical trial regulatory aspects of early phase studies.
'/>"/>

SOURCE Medpace, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Facet Solutions, Inc. Appoints Industry Veteran to Board of Directors
2. Phyhealth Appoints Gerald H. Priceman as Medical Director
3. Halleland Health Consulting Hires New Director of Lifescience Business Development Peter T. Bianco
4. NightHawk Radiology Holdings, Inc. Announces Appointment of David Engert to the Board of Directors
5. Seattle-Based Marsha Rivkin Center for Ovarian Cancer Research Appoints Nancy Sclater, Executive Director
6. Allen Kukovich, Director, Governors Southwest PA Office, Joins Call for Quality Affordable Health Insurance
7. Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
8. Executive Director of cbm US congratulates UN on Malaria Campaign
9. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
10. US Oncology Welcomes New Director of Federal Government Relations
11. Steris Corporation Announces the Appointment of Two New Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Williamsport, PA (PRWEB) March 06, 2015 ... warning of a national shortfall of 90,000 doctors by ... media, Susquehanna Health (SH) is proactively preparing ... development, recruitment and patient access. , Several factors ... population, increasing number of insured under the Affordable Care ...
(Date:3/6/2015)... First Choice Emergency Room opened ... is located at 13351 W. Bowles Avenue, Littleton, Colorado and ... ready 24-7 to provide the highest quality emergency medical care ... of First Choice Emergency Room Littleton. , First ... Metro Denver Chamber of Commerce and a medical community open ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Magellan Rx ... only comprehensive source for key trends and statistics on ... medical injectables. Executives from Magellan Rx Management will discuss ... Report: Discover Your Hidden Specialty Drug Spend,” a complimentary ... Services, Inc. , Specialty drug spend makes up more ...
(Date:3/6/2015)... NC (PRWEB) March 06, 2015 In a ... of Polish mesothelioma patients reported that shoulder pain was their ... story on its website. Click here to read it ... Warsaw analyzed the medical records of 49 mesothelioma patients ... them reported that it was shoulder pain that first prompted ...
(Date:3/6/2015)... 2015 You Wealth Revolution ( ... unique ‘energy’ experiment to determine if quick remote ... After quick ‘5 -7 minute’ remote energy and ... reported their life improving - often times very ... , According to research, respondents saw the following ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2
... the brain may be to blame, MRI study shows , ... blood flow to the brains of Alzheimer,s patients and exacerbates ... A team at the University of Pittsburgh used MRI to ... patients (10 with hypertension and 10 without); 48 normal adults ...
... 30 Caraco Pharmaceutical,Laboratories, Ltd., (Amex: CPD ... Drug,Administration (FDA) has granted tentative approval for the ... Tablets,(escitalopram), 5 mg, 10 mg, and 20 mg., ... major depressive,disorder. This tentative approval is for the ...
... Forces - Urge Reinvestment of Billions into Medicare,Program, ... the State of New York, and StateWide Senior Action ... to lead the U.S. Senate in,strengthening Medicare by protecting ... and helping lower income,persons pay for prescription drugs. These ...
... U-M Museum of Art to display selected,works by Michigan ... ARBOR, Mich., Nov. 30 More than 50 years,ago, ... dozens of great moments in medical history, from ancient,Egypt ... Within a few years, the entire nation knew the ...
... Progressive Clinic Will Offer Assessments for Diabetic Retinopathy, a ... Leading Cause ... a Wake,Forest, NC company specializing in retinal risk assessment for diabetics,announced ... Retasure solution to provide retinal imaging risk assessment., MacGregor Medical ...
... mind to those living with food allergies, WHITE ... Americans suffer from food allergies. For most, it means ... severe or even fatal,reactions., Now those with food ... are pre-printed, re-positional Post-It(R) notes that help,alert others to ...
Cached Medicine News:Health News:High Blood Pressure Could Exacerbate Alzheimer's 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R) 2Health News:Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 2Health News:Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 3Health News:A Major Gift of Art and History: U-M Receives 45 Significant Medical Paintings From Pfizer 2Health News:A Major Gift of Art and History: U-M Receives 45 Significant Medical Paintings From Pfizer 3Health News:A Major Gift of Art and History: U-M Receives 45 Significant Medical Paintings From Pfizer 4Health News:Digital Healthcare Announces MacGregor Medical Center San Antonio to Utilize Retasure for Retinal Imaging Assessment 2Health News:AllerNotes Help Take Food Allergies Off the Table 2
(Date:3/6/2015)... FOREST, Ill. , March 6, 2015   Hospira, ... the U.S. Food and Drug Administration (FDA) on today,s FDA ... States . This is a watershed moment for improving ... As a leading global provider of biosimilars, Hospira has seen ... we are a proud participant in these early stages of ...
(Date:3/6/2015)... , March 6, 2015  Abaxis, Inc. (NasdaqGS: ... point-of-care instruments and consumables for the medical, research, and ... the veterinary and research markets in the ... for Veterinary Biologicals of the U.S. Department of Agriculture ... for the detection of   A. phagocytophelium and ...
(Date:3/6/2015)... , March 6, 2015   Veracyte, Inc. ... data demonstrating that diagnostic tests that use increasing numbers ... dramatically reduce the specificity of test results, leading to ... are erroneously diagnosed as cancerous. In addition, these new ... of the malignancies leading to "false negatives." The data ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6
... The American Pharmacists Association would like to remind ... pharmacist during cold and flu season. A pharmacist can ... shot, identifying the differences between a common cold and ... a recommendation when a health care provider should be ...
... LAKE ZURICH, Ill. and HACKENSACK, N.J., Jan. 18, 2011 ... of Hackensack, N.J., announced today they have signed an ... range of Genesis-branded products for blood centers, plasma centers ... The agreement covers products such as Genesis™ blood ...
Cached Medicine Technology:Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season 2Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season 3Fenwal, GenesisBPS Enter Agreement for Blood-Specialty Products 2
The NPT7 blood gas analyzer measures pH/blood gases and oximetry on 90 L sample volume with a two-step sampling procedure. Clinical tests compare NPT7 accuracy to that of benchtop analyzers. 30 sampl...
... GEM Premier 3000 simplifies and ... addition to unique features such ... and comprehensive menu options, the ... Intelligent Quality Management (iQM), an ...
... IRMA TRUpoint sets the standard for ... chemistries right at your patient's side ... This powerful, self contained system can ... CCU to ICU, or wherever you ...
Mini-flatbed agitator....
Medicine Products: